Citadel Advisors
ICVX

Citadel Advisors’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Citadel Advisors’s Portfolio ICVX Stock Details ICVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-275,779
Closed -$4.35M – 15792
2023
Q4 		$4.35M Sell
275,779
-1,326,993
-83% -$12.8M ﹤0.01% 4008
2023
Q3 		$12.4M Sell
1,602,772
-582,238
-27% -$4.83M ﹤0.01% 2412
2023
Q2 		$21.7M Buy
2,185,010
+617,302
+39% +$4.94M ﹤0.01% 1803
2023
Q1 		$9.09M Sell
1,567,708
-2,822
-0.2% -$24.4K ﹤0.01% 2935
2022
Q4 		$12.5M Sell
1,570,530
-123,204
-7% -$529K ﹤0.01% 2510
2022
Q3 		$5.35M Buy
1,693,734
+126,026
+8% +$788K ﹤0.01% 3750
2022
Q2 		$8.98M Buy
1,567,708
+84,336
+6% +$658K ﹤0.01% 2837
2022
Q1 		$10.4M Buy
1,483,372
+274,647
+23% +$4.32M ﹤0.01% 2880
2021
Q4 		$27.3M Hold
1,208,725
– – 0.01% 1696
2021
Q3 		$35.2M Buy
+1,208,725
New +$41M 0.01% 1422

Citadel Advisors's ICVX Position: Q1 2024 in Review

Citadel Advisors sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 275,779 shares — an estimated $4.35M sold.

Citadel Advisors first reported a position in ICVX in Q3 2021 and held it in 10 quarters. The position peaked at $35.2M in Q3 2021. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

  • Citadel Advisors reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Citadel Advisors sold 275,779 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $4.35M.
  • Citadel Advisors first reported a position in Icosavax, Inc. Common Stock in Q3 2021 and held it in 10 quarters.
  • Citadel Advisors's Icosavax, Inc. Common Stock position peaked at $35.2M in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.